PMC6613052_01
Preoperative macular edema.. Spectral-domain OCT showed a cystoid macular edema with subretinal fluid.. OCT, optical coherence tomography.
10.1177_2515841419856520-fig1.jpg
PMC6613052_01_10.1177_2515841419856520-fig1.jpg
fig1-2515841419856520
Macular optical coherence tomography (OCT) showed a central macular thickness of 890 m, cystoid macular edema, and subretinal liquid (Figure 1).
Surgical technique: (a) we sutured one of the ends of the implant with nonabsorbable polypropylene (Prolene; Ethicon, UK) 10-0; (b) after performing a 23-G sclerotomy at the 6 o'clock position (3.5 mm from the corneal limbus), using forceps we introduced the implant through the sclerotomy into the vitreous cavity.
10.1177_2515841419856520-fig2.jpg
PMC6613052_01_10.1177_2515841419856520-fig2.jpg
fig2-2515841419856520
UK) (Figure 2(a)). Under regional anesthesia, a 23-G sclerotomy was performed at a 3.5 mm distance from the limbus. The implant was then introduced through the sclerotomy into the vitreous cavity using forceps (Figure 2(b)).
Postoperative period: (a) at 1 week after OZURDEX scleral fixation, the implant could be easily observed behind the iris at the 6 o'clock position on slit-lamp examination. (b) Swept source OCT shows no cystoid macular edema or subretinal fluid.. OCT, optical coherence tomography.
10.1177_2515841419856520-fig3.jpg
PMC6613052_01_10.1177_2515841419856520-fig3.jpg
fig3-2515841419856520
Ozurdex implant was properly placed and fixed behind the iris at the 6 o'clock position (Figure 3(a)). The cornea was clear and the measured central macular thickness decreased from 890 to 252 m, without cystoid macular edema or subretinal fluid (Figure 3(b)).